All Sauce from Weekly Sauce:

An experimental blood test might be able to predict whether glaucoma patients will continue to lose their vision following treatment, researchers report. A biochemical called nicotinamide adenine dinucleotide (NAD) tends to be lower in people with glaucoma compared to those without the eye disease, researchers found. What’s more, glaucoma patients with lower NAD levels than…  read on >  read on >

More than four years after the pandemic began, childhood vaccination rates worldwide have yet to recover, a new report shows. The latest data, issued Monday by the World Health Organization and the United Nations International Children’s Emergency Fund (UNICEF), underscore the need for continuing to try to catch-up to pre-pandemic levels. “The latest trends demonstrate…  read on >  read on >

An experimental drug appears to help women deal with stress incontinence, clinical trial data show. The drug, for now dubbed TAS-303, reduced the frequency of leaks related to stress incontinence by about 58%, compared with 47% reduction in a placebo group, trial results show. Further, about 65% of patients taking TAS-303 had their stress incontinence…  read on >  read on >

Over-the-counter nasal sprays could be a potent weapon against a major public health threat — antibiotic resistance, researchers report. Their analysis, which looked at data from nearly 14,000 adults, found that common nasal sprays could help keep upper respiratory tract infections at bay, reducing the need for antibiotics. Antibiotic resistance caused by overuse and misuse…  read on >  read on >

Some diabetes drugs appear to lower the risk that people with type 2 diabetes will develop dementia or Alzheimer’s disease, a new evidence review says. The risk of dementia and Alzheimer’s is significantly lower in patients treated with metformin or a class of meds called “sodium glucose co-transporter-2 (SGLT-2) inhibitors”, compared with other diabetes drugs,…  read on >  read on >